ClinVar Miner

Variants studied for Amyotrophic lateral sclerosis

Coded as:
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign association risk factor total
6 21 105 6 5 1 2 145

Gene and significance breakdown #

Total genes and gene combinations: 58
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign association risk factor total
FIG4 0 1 13 1 0 0 0 14
SETX 0 2 8 0 0 0 0 10
SPG11 0 0 10 0 0 0 0 10
DCTN1 0 2 4 0 2 0 0 8
ERBB4 0 1 6 0 1 0 0 8
CHRNA3 0 4 1 0 0 0 0 5
DAO 0 1 3 1 0 0 0 5
SOD1 3 2 0 0 0 0 0 5
ALS2 0 3 1 0 0 0 0 4
ANXA11 0 1 3 0 0 0 0 4
CHRNA4 0 0 1 2 0 0 0 3
CHRNB4 0 0 1 0 2 0 0 3
KIF5A 0 0 3 0 0 0 0 3
NEFH 0 0 3 0 0 0 0 3
SQSTM1 0 1 2 0 0 0 0 3
TBK1 2 1 0 0 0 0 0 3
UNC13A 0 0 2 0 0 1 0 3
C9orf72, LOC109504728, LOC129929032 1 0 1 0 0 0 0 2
EWSR1 0 0 2 0 0 0 0 2
GLE1, LOC101929270 0 0 2 0 0 0 0 2
MATR3 0 0 2 0 0 0 0 2
NEK1 0 0 2 0 0 0 0 2
OPTN 0 0 2 0 0 0 0 2
PFN1 0 0 2 0 0 0 0 2
PNPLA6 0 0 2 0 0 0 0 2
SCFD1 0 0 2 0 0 0 0 2
SPTLC1 0 1 1 0 0 0 0 2
ABCA7 0 0 1 0 0 0 0 1
ANG, EGILA, RNASE4 0 0 1 0 0 0 0 1
ATXN2 0 0 1 0 0 0 0 1
ATXN2, LOC130008791 0 0 0 0 0 0 1 1
CAPN14 0 0 1 0 0 0 0 1
CCNF 0 0 1 0 0 0 0 1
CCNF, LOC105371050 0 0 1 0 0 0 0 1
CFAP410 0 0 1 0 0 0 0 1
CHCHD10 0 0 1 0 0 0 0 1
DDX20 0 0 1 0 0 0 0 1
DNAJC7 0 0 1 0 0 0 0 1
DYNC1H1 0 0 1 0 0 0 0 1
ELP3 0 0 1 0 0 0 0 1
FUS 0 0 1 0 0 0 0 1
GLT8D1 0 0 1 0 0 0 0 1
KANK1 0 0 1 0 0 0 0 1
LOC108903148, OPTN 0 0 1 0 0 0 0 1
LOC126807526, MATR3 0 0 1 0 0 0 0 1
LOC126860782, SETX 0 0 1 0 0 0 0 1
LOC130056709, NIPA1 0 0 0 0 0 0 1 1
MOBP 0 0 1 0 0 0 0 1
PON1 0 0 1 0 0 0 0 1
PON3 0 0 0 1 0 0 0 1
PRPH, TROAP 0 0 1 0 0 0 0 1
SARM1 0 0 1 0 0 0 0 1
SOD1, SOD1-DT 0 0 1 0 0 0 0 1
SS18L1 0 0 1 0 0 0 0 1
TNIP1 0 0 1 0 0 0 0 1
TUBA4A 0 0 1 0 0 0 0 1
UBQLN2 0 0 0 1 0 0 0 1
VCP 0 1 0 0 0 0 0 1

Submitter and significance breakdown #

Total submitters: 15
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign association risk factor total
UM ALS/MND Lab, University Of Malta 0 8 39 0 0 0 2 49
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, Koc University 0 6 21 5 5 0 0 37
Dept. of Medical Genetics, Telemark Hospital Trust, Telemark Hospital Trust 4 3 26 0 0 0 0 33
Inherited Neuropathy Consortium Ii, University Of Miami 0 0 10 0 0 0 0 10
Molecular Genetics, Royal Melbourne Hospital 1 1 4 0 0 0 0 6
Genomic Research Center, Shahid Beheshti University of Medical Sciences 0 0 1 1 0 0 0 2
Human Genetics Bochum, Ruhr University Bochum 0 1 1 0 0 0 0 2
Center of Genomic medicine, Geneva, University Hospital of Geneva 1 0 0 0 0 0 0 1
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen 1 0 0 0 0 0 0 1
Bonnemann Lab, National Institutes of Health 0 1 0 0 0 0 0 1
University Research Institute for the Study of Genetic and Malignant Disorders in Childhood, National and Kapodistrian University of Athens 0 0 1 0 0 0 0 1
Department of Human Genetics, Hannover Medical School 0 0 1 0 0 0 0 1
Motor Neurone Disease Genetics and Therapeutics, Perron Institute for Neurological and Translational Science 0 0 1 0 0 0 0 1
Neurogenomics Lab, Neuroscience Institute, University Of Cape Town 0 1 0 0 0 0 0 1
Department of Research, Sir Ganga Ram Hospital 0 0 0 0 0 1 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.